SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SemiBull who wrote (1531)5/14/2003 10:07:35 PM
From: scott_jiminez  Read Replies (1) of 3044
 
<<The company consumed $120 million of cash for the three months ended March 31, 2003.>>

Geez with that sort of largesse they are depending on squeezing every drop of profit out of Velcade (and Integrilin).

Always a highly risky proposition for new drugs.

S&P's hesitant and conservative approach appears to be completely appropriate, if not somewhat of a cautionary flag, in the wake of all the recent hype.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News